We aimed to determine whether the severity of inhalation injury evokes an immune response measurable at the systemic level and to further characterize the balance of systemic pro-and anti-inflammation early after burn and inhalation injury. Background: Previously, we reported that the pulmonary inflammatory response is enhanced with worse grades of inhalation injury and that those who die of injuries have a blunted pulmonary immune profile compared with survivors. Methods: From August 2007 to June 2011, bronchoscopy was performed on 80 patients admitted to the burn intensive care unit when smoke inhalation was suspected. Of these, inhalation injury was graded into 1 of 5 categories (0, 1, 2, 3, and 4), with grade 0 being the absence of visible injury and grade 4 corresponding to massive injury. Plasma was collected at the time of bronchoscopy and analyzed for 28 immunomodulating proteins via multiplex bead array or enzyme-linked immunosorbent assay. Results: The concentrations of several plasma immune mediators were increased with worse inhalation injury severity, even after adjusting for age and % total body surface area (TBSA) burn. These included interleukin (IL)-1RA (P = 0.002), IL-6 (P = 0.002), IL-8 (P = 0.026), granulocyte colonystimulating factor (P = 0.002), and monocyte chemotactic protein 1 (P = 0.007). Differences in plasma immune mediator concentrations in surviving and deceased patients were also identified. Briefly, plasma concentrations of IL-1RA, IL-6, IL-8, IL-15, eotaxin, and monocyte chemotactic protein 1 were higher in deceased patients than in survivors (P < 0.05 for all), whereas IL-4 and IL-7 were lower (P < 0.05). After adjusting for the effects of age, % TBSA burn, and inhalation injury grade, plasma IL-1RA remained significantly associated with mortality (odds ratio, 3.12; 95% confidence interval, 1.03-9.44). Plasma IL-1RA also correlated with % TBSA burn, inhalation injury grade, fluid resuscitation, Baux score, revised Baux score, Denver score, and the Sequential Organ Failure Assessment score. Conclusions: The severity of smoke inhalation injury has systemically reaching effects, which argue in favor of treating inhalation injury in a graded manner. In addition, several plasma immune mediators measured early after injury were associated with mortality. Of these, IL-1RA seemed to have the strongest correlation with injury severity and outcomes measures, which may explain the blunted pulmonary immune response we previously found in nonsurvivors.
hypermetabolic response to injury, and modern advancements in critical care with appreciation for acute lung injury have all dramatically improved our ability to support the severely burn-injured patient. 1 Despite these advancements, however, inhalation injury remains a significant contributor to mortality, increasing its likelihood by as much as 25%. 2 Inhalation injury is also relatively common among patients with burns, yet there remains no standard for its diagnosis, scoring, and subsequent treatment. Furthermore, as surgeons and critical care specialists, our understanding of the local and systemic inflammatory response to injury and sepsis continues to evolve, particularly in light of failed clinical trials designed to modulate the immune response to these conditions. Recent studies are also challenging the paradigm of a systemic inflammatory response syndrome that shifts over time to a compensatory anti-inflammatory response syndrome, in that the pro-and anti-inflammatory response to injury and sepsis appears as processes with considerable overlapping. 3 Understanding the interplay between these mediators in the face of critical illness remains at the forefront of clinical and laboratory research efforts.
Concurrent to the evolving understanding of local and systemic inflammatory responses to injury and sepsis, we have found that in burned patients with smoke inhalation the pulmonary inflammatory response is enhanced with worse grades of inhalation injury and that those who die of injuries have a blunted pulmonary immune responsiveness compared with survivors. 4, 5 On the basis of conclusions of these prior studies, we sought to answer 2 important questions: (1) Does the severity of inhalation injury evoke an immune response measurable at the systemic level? and (2) Does the systemic immune response to burn and smoke inhalation explain the pulmonary immune hyporesponsiveness that we have seen in nonsurvivors? Therefore, this report investigated the plasma immune response early after burn and smoke inhalation, aiming to describe the balance of circulating pro-and anti-inflammatory mediators and to correlate the systemic immune profile with both the severity of inhalation injury and outcomes. immunosuppressive medications, the presence of malignancy, autoimmune condition, chronic inflammatory disease, or declining study participation. Plasma was collected at the time of bronchoscopy, which was within 15 hours of injury in all cases. The plasma of 17 nonsmoking healthy adult volunteers, free of known pulmonary, cardiac, infectious, allergic, autoimmune, or cancerous disease, was also assessed for comparison.
Clinical variables and outcomes of interest were recorded, including age, sex, race/ethnicity, % total body surface area (% TBSA) burn, Baux score (age + % TBSA), revised Baux score [age + % TBSA + 17 × Inhalation injury (0 = No, 1 = Yes)], 6 Denver score, Sequential Organ Failure Assessment score, 24-and 72-hour fluid resuscitation (mL/kg), grade of inhalation injury, % plasma carboxyhemoglobin, initial 48-hour and full-hospitalization nadir of the ratio of plasma oxygen content to fraction of inspired oxygen (P:F ratio), initial 48-hour and full-hospitalization peak of plasma creatinine and bilirubin, frequency of pneumonia, sepsis, and tracheostomy, ventilator days, ventilator-free days, intensive care unit length of stay, hospital length of stay, and mortality. Pneumonia and sepsis were defined according to American Burn Association Consensus Conference criteria. 7 Mortality was defined as any death from the time of injury to discharge from our tertiary burn center. This study was conducted under institutional review board approval.
Grading of Inhalation Injury and Sample Processing
During bronchoscopy, inhalation injury was graded into 1 of 5 categories (0, 1, 2, 3, and 4), based on Abbreviated Injury Score criteria, with grade 0 being the absence of visible injury and grade 4 corresponding to massive injury. 8 Plasma was analyzed in duplicate for 28 immunomodulating proteins via multiplex immunoassay (Bio-Rad Laboratories, Hercules, CA) or enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN) as previously described and according to manufacturer instructions. 9 These results were compared for those with different grades of inhalation injury and outcomes.
Statistical Analysis
All data were assessed for normality and parametric or nonparametric tests were applied where appropriate. Dichotomous variables are reported as a percentage and number, nonparametric variables are reported as a median with the interquartile range, and continuous variables of parametric tests are reported as a mean with standard deviation. Multivariable regression was performed on the basis of log-transformed data to adjust for relevant confounders. Statistical analyses were calculated with SAS version 9.1 (SAS Institute Inc, Cary, NC).
RESULTS

Demographics, Clinical Characteristics, and Outcomes
Bronchoscopy was performed on 80 patients suspected of inhalation injury; of these, 72 had no exclusion criteria and were enrolled in these investigations. The median (interquartile range) time from injury to bronchoalveolar lavage fluid (BALF) and plasma collection was 6 (5-10) hours. Patients had a median age of 49 years, 40% were women, and had the following distribution of inhalation injury grades: grade 0 (n = 13); grade 1 (n = 16); grade 2 (n = 18); grade 3 (n = 20); and grade 4 (n = 5). The mean (standard deviation) % TBSA burn of the entire cohort was 20.2% (± 23.2%), and the median (interquartile range) % TBSA burn was 12.5% (1.0-31.3%). No patient died during the initial 72 hours of resuscitation, and the subsequent primary causes of mortality were the following: multiple organ failure (n = 8), cardiogenic shock (n = 4), septic shock (n = 1), acute respiratory distress syndrome (n = 1), carbon monoxide poisoning (n = 1), and massive cerebrovascular accident (n = 1). Of the 16 mortalities, 11 involved withdrawal of care when further heroic efforts became futile. Table 1 demonstrates data corresponding to survival status, with select comparisons represented in Figure 1 . Compared with survivors (n = 56), those who succumbed to their injuries (n = 16) were older (median 64 vs 46 years; P = 0.005), had fewer ventilator-free days (median 0 vs 6; P < 0.001), and had a greater % TBSA burn (median 38 vs 8; P < 0.001), Baux score (median 96.0 vs 61.0; P < 0.0001), revised Baux score (median 113.0 vs 76.0; P < 0.0001), Denver score (median 6 vs 2, P < 0.0001), Sequential Organ Failure Assessment score (median 10 vs 4; P < 0.0001), 24-hour fluid resuscitation (median 185 mL/kg vs 74 mL/kg; P < 0.001), and 72-hour fluid resuscitation (median 351 mL/kg vs 187 mL/kg; P < 0.001). Indeed, 25% of deceased patients compared with only 5% of survivors exceeded a 24-hour fluid resuscitation of 250 mL/kg (P = 0.039), reaffirming this potentially important cutoff. 10 Likewise, deceased patients also had a lower initial 48-hour P:F ratio nadir (median 142.5 vs 207.5; P = 0.003) and had a greater peak of plasma creatinine and bilirubin levels during their hospitalization [median 2.50 vs 1.03 (P < 0.001) and median 1.3 vs 0.8 (P < 0.001), respectively]. Finally, deceased patients had a greater frequency of sepsis (38% vs 8%) and pneumonia (69% vs 45%), although these clinically relevant comparisons fell short of statistical significance (P < 0.10 for both).
Plasma Immune Mediator Concentrations According to Smoke Inhalation Severity and Burn Size
The primary focus of this study was to determine whether or not the severity of smoke inhalation induced systemic immune mediator changes. Of the 72 patients enrolled in the study, 64 had plasma collected at the time of bronchoscopic diagnosis of their inhalation injury. We found that the concentrations of several plasma immune mediators were increased with worse inhalation injury severity, even after adjusting for age and % TBSA burn ( Table 2 ). These included interleukin (IL)-1RA (P = 0.002), IL-6 (P = 0.002), IL-8 (P = 0.026), granulocyte colony-stimulating factor (P = 0.002), and monocyte chemotactic protein 1 (P = 0.007). Likewise, the following plasma mediators were also increased with worse inhalation injury, although they failed to reach statistical significance: IL-1β (P = 0.078), IL-10 (P = 0.075), IL-15 (P = 0.060), and tumor necrosis factor α (P = 0.099).
Plasma Cytokine, Chemokine, and Growth Factors as Related to Mortality
Differences in plasma immune mediator concentrations in surviving and deceased patients were identified (Table 3) . Those most researched in burns, trauma, and sepsis, and/or which we found at physiologically relevant levels, are shown in Figure 2 . Plasma concentrations of IL-1RA, IL-6, IL-8, IL-15, eotaxin, and monocyte chemotactic protein 1 were higher in deceased patients than in survivors (P < 0.05 for all), whereas IL-4 and IL-7 levels were lower (P < 0.05). After adjusting for the effects of age, % TBSA burn, and inhalation injury grade, plasma IL-1RA remained significantly associated with mortality (odds ratio, 3.12; 95% confidence interval, 1.03-9.44). Likewise, deceased patients had a much lower IL-1β to IL-1RA ratio than survivors (P = 0.0001) ( Fig. 2 ). Of note is that the timing of plasma sample collection did not differ between survivors and nonsurvivors (P = 0.479). P = 0.005). In addition to being associated with mortality in patients with burns, numerous plasma immune mediator concentrations correlated significantly with injury severity and outcomes. Those mediators most studied in burn care and with the strongest correlations to % TBSA, inhalation injury grade, 24-hour fluid resuscitation, revised Baux score, Denver score, SOFA score, initial 48-hour P:F nadir, hospital LOS, and mortality are demonstrated in Table 4 . Again, high levels of plasma IL-1RA were the most associated with injury severity and numerous outcome measures, although plasma IL-6, IL-8, and monocyte chemotactic protein 1 had similarly significant correlations. Finally, the ratio of plasma IL-1β to IL-1RA was negatively correlated with Baux score (r = −0.380, P = 0.002), revised Baux score (r = −0.372, P = 0.003), Denver score (r = −0.250, P = 0.046), 72-hour fluid resuscitation (r = −0.278, P = 0.030), and mortality (r = −0.487, P < 0.0001).
DISCUSSION
The results of our study are 3-fold. First, numerous routine clinical parameters and indicators of outcome were associated with mortality, which substantiates the generalizability of our data. 1, 2, 8, [11] [12] [13] [14] [15] [16] Second, the severity of smoke inhalation injury seemed to induce systemically measurable effects, in that plasma concentrations of IL-1RA, IL-6, IL-8, granulocyte colony-stimulating factor, and monocyte chemotactic protein 1 were increased with worse grades of inhalation injury. And third, several plasma immune mediators measured early after injury were associated with mortality, including IL-1RA, IL-4, IL-6, IL-7, IL-8, IL-15, eotaxin, and monocyte chemotactic protein 1. Of these, increased plasma concentrations of antiinflammatory IL-1RA (and therefore a reduced ratio of IL-1β to IL-1RA) had the strongest correlations with injury severity, outcome measures, and mortality, which may have contributed to the blunted pulmonary immune response we previously found in nonsurvivors. 5 Abundant animal and human studies have investigated the immune response to burns, trauma, and sepsis, implicating both proand anti-inflammatory responses as potential determinants of outcomes and survival. To date, however, no single mediator, be it pro-or anti-inflammatory, has been identified as a successful candidate for immunomodulation despite attempts in phase I, phase II, and even phase III clinical trials. These findings suggest either that our understanding of the immune response to burns, trauma, and sepsis is incomplete or that our approach to immunomodulation of inherently heterogeneous patients with a single mediator is inappropriate. Indeed, our study affirms the recent finding of Xiao et al, 3 which indicated a simultaneous induction of pro-and anti-inflammatory processes after injury. These data suggest that an appreciation for the balance of inflammatory signaling may be most crucial to efforts at modulating the immune profile after burn injury.
This study is important because it is only the second of which we are aware as having identified inhalation injury as inducing systemic immune mediator changes. Previously, Rodriguez et al 40 reported that the addition of inhalation injury magnified the amount of circulating IL-8 detected. In our study, the systemic effects of inhalation injury are evidenced by numerous plasma immune mediator concentrations being elevated in response to more severe grades of inhalation injury, even after adjusting for relevant variables such as age and % TBSA burn. These findings are in contrast to those of Finnerty et al, 41 who also tested the hypothesis that inhalation injury augments the systemic inflammatory response. In a study of 72 children, they failed to demonstrate that the presence of inhalation injury altered the systemic immune profile as determined by changes in plasma immune mediator concentrations. However, as compared with our study of adults with a mean % TBSA burn of 20%, the sample population in the study of Finnerty et al consisted of children with and without inhalation injury, who had a mean % TBSA burn of approximately 60% or more. Not only then was the size of burn injury considerably different than in our study but also was the population age, which is known to influence the immune response to injury and is a factor actively investigated at our own institution. Therefore, comparisons between our study and theirs may be difficult, especially as the study of Finnerty et al did not take into account the severity of inhalation injury, which, as we have observed, is an important determinant of the systemic immune response to burns combined with smoke inhalation. Further yet, plasma and BALF samples were collected in our study in a well-defined postinjury window of approximately 5 to 10 hours, thus minimizing the effect of time since injury on immune mediator concentrations. all values in pg/mL of plasma. FGF indicates fibroblast growth factor; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN-γ , interferon γ ; MIP, macrophage inhibitory protein; PDGF, platelet-derived growth factor; TNF, tumor necrosis factor α; VEGF, vascular endothelial growth factor.
Having previously found that the pulmonary immune response is blunted in nonsurvivors of burn and smoke inhalation injury, 5 we also sought to identify a circulating mediator of anti-inflammation potentially responsible for this phenomenon. Of all 28 plasma immunomodulating proteins that we examined within 15 hours of injury, an elevated plasma concentration of IL-1RA was most predictive of mortality, independent of age, % TBSA burn, and inhalation injury grade. This finding provides a plausible explanation for the pulmonary immune anergy that we previously identified in nonsurvivors of burn and inhalation injury. 5 Moreover, IL-1RA, and the imbalance of IL-1α/β to IL-1RA signaling, could serve as a legitimate target for future research. 42 For instance, in a study of 31 burn-injured patients, Abbreviations as in Table 2 .
Cannon et al 43 found that the low level of circulating IL-1β was associated with mortality. As other studies had noted a similar role of IL-1α/β in human and animal survival from sepsis, [44] [45] [46] [47] [48] [49] Cannon et al concluded that IL-1β is an essential component of the host defense to injury. Indeed, Kupper et al 50 found that defective antigen presentation after burn injury could be restored with IL-1β, and Mancilla et al 47 found that high doses of IL-1RA decreased survival in an animal model of Klebsiella infection. Finally, more recent studies in burns, trauma, and sepsis validate the hypothesis that insufficient IL-1α/β or excessive IL-1RA results in systemic immune dysfunction that may be detrimental to survival. [51] [52] [53] As phase III trials investigating IL-1RA therapy in severe sepsis have been disappointing, 19 one may surmise then that some degree of IL-1 signaling could be important for various facets of the immune response to injury and sepsis, such as B-and T-cell proliferation, activation of neutrophils and macrophages, and release of hematopoietic factors. [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] Yet, data are conflicting regarding the role of IL-1 after burn injury, particularly as mice deficient in IL-1 receptor-associated kinase-1 have been shown to have less cardiac contractile dysfunction after burns than their wild-type counterparts. 67 In addition, IL-1RA synthesis may be differentially regulated among individuals, which could explain why some have an enhanced production of this anti-inflammatory cytokine, independent from even age, % TBSA burn, and inhalation injury grade. 68 Future studies are warranted to examine the role of IL-1RA as a mediator of subsequent outcome in patients with burns by understanding its mechanistic role in immune signaling, which could very well involve IL-6 and IL-8 through mitogen-activated protein kinase and NF-κB pathways, in addition to steric inhibition of IL-1α/β binding to their membrane-bound receptors. 69 Alterna-tively, early measurement of IL-1RA may serve as an ideal candidate for predicting outcomes in patients with burns. Several other cytokines and chemokines that our study identified as correlating with morbidity and mortality have been frequently implicated as important mediators of injury response and outcome, most notably IL-6 and IL-8. For instance, we found that plasma concentrations of IL-6 were elevated early after injury in nonsurvivors and that higher levels of IL-6 correlated with inhalation injury grade, fluid resuscitation, pulmonary dysfunction, and subsequent multiple organ failure and death. Similar findings to ours have been routinely published in other studies of burns, trauma, and sepsis, whereby IL-6 is elevated in those at greatest risk for poor outcomes. [70] [71] [72] [73] [74] [75] [76] [77] [78] As with many mediators of the immune response to injury, the precise role of IL-6 (which has demonstrated both pro-and anti-inflammatory effects) other than as a marker of disease severity remains unclear. [79] [80] [81] [82] [83] [84] Along these lines, knockout studies in mice have demonstrated IL-6 to be important for the stimulation of hepatic glutamine transportation after burn injury and in mediating myocardial dysfunction after burn injury in the setting of sepsis. 67, 85, 86 Moreover, animal models of burn injury using IL-6-deficient mice and wild-type mice given neutralizing concentrations of anti-IL-6 antibody have suggested beneficial effects to cell-mediated immunity, cytokine production, and organ function with reduced or absent IL-6. [87] [88] [89] Our study also seems to confirm IL-8 as an important determinant and/or marker of outcomes in patients with burns. As a chemokine, IL-8 primarily serves both to recruit neutrophils to the site of injury and to activate their expression of surface adhesion molecules, degranulation, and oxidative burst capacity. Likewise, IL-8 is frequently identified as a correlate to morbidity and mortality in FIGURE 2. Select immune mediators in the plasma of patients within 15 hours of burn and smoke inhalation injury, comparing survivors and deceased. IL-1RA (B), IL-6 (D), IL-8 (E), and monocyte chemotactic protein 1 (H) were increased in deceased patients, whereas the ratio of IL-1β to IL-1RA was markedly decreased ( * P < 0.05). The concentrations of IL-1β (A), granulocyte colonystimulating factor (F), granulocyte-macrophage colony-stimulating factor (G), and tumor necrosis factor α (I) were statistically not different between groups. After adjusting for the effects of age, % TBSA burn, and inhalation injury grade, the concentration of IL-1RA remained significantly associated with mortality ( †odds ratio, 3.12; 95% confidence interval, 1.03-9.44).
animals and patients with burns, trauma, and sepsis. 34, 35, 40, 76, [90] [91] [92] As with IL-1RA, IL-6, and the balance of pro-and anti-inflammation, further studies are required to better elucidate the role for locally produced and circulating IL-8 as an effecter of outcomes in patients with burns. Such investigations are ongoing at our burn center and research laboratories, with the aim through translational studies to further refine our understanding of the immune response to injury, especially among specific groups of patients who vary in terms of sex, age, and alcohol intoxication. These investigations will continue to involve injury response modification through antibody suppression, transgenic animal models, and elucidation of intracellular signaling pathways.
We acknowledge important limitations to our study. First, although a sample size of 72 patients is relatively robust, the specificity of our results is hindered by the heterogeneity of the study popula-tion, particularly along the lines of age and % TBSA burn. However, our regression approach accounted for the most important effectors of outcome. Second, our study has an inherent selection bias, in that only those with a suspected inhalation injury were candidates for enrollment, thereby excluding many with skin burns alone. Nonetheless, many widely accepted correlations with outcomes were applicable to our study population, such as age, % TBSA burn, and measures of organ dysfunction, rendering our results interpretable and generalizable to the majority of burn-injured patients. Third, the data are limited to the acute phase of injury response, in that the concentrations of plasma immune mediators were assessed within 15 hours of injury. Therefore, our study examines the immune response to injury neither during the full resuscitation phase nor during the course of hospitalization. Finally, our study does not provide mechanistic data that may hold additional clues as to how seemingly important FGF indicates fibroblast growth factor; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN-γ , interferon γ ; LOS, length of stay; MIP, macrophage inhibitory protein; PDGF, platelet-derived growth factor; SOFA, Sequential Organ Failure Assessment; TNF, tumor necrosis factor α; VEGF, vascular endothelial growth factor. mediators of injury, such as IL-1β, IL-1RA, IL-6, and IL-8, may induce their effects. We hope that continued patient enrollment, collaboration with other centers, and additional bench-side studies will advance our understanding of the immune response to burn injury, trauma, and sepsis.
We conclude that the early anti-inflammatory response to burn and smoke inhalation injury may play a significant role in subsequent outcome and that it could still serve as a potential target for therapeutic intervention. We also conclude that the severity of smoke inhalation injury evokes systemically reaching effects that alter the immune response to injury, arguing in favor of treating inhalation injury in a graded manner.
